These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 28215653

  • 1. Dendritic cells infected by Ad-sh-SOCS1 enhance cytokine-induced killer (CIK) cell immunotherapeutic efficacy in cervical cancer models.
    Zheng Y, Hu B, Xie S, Chen X, Hu Y, Chen W, Li S, Hu B.
    Cytotherapy; 2017 May; 19(5):617-628. PubMed ID: 28215653
    [Abstract] [Full Text] [Related]

  • 2. Enhanced immunotherapeutic effect of modified HPV16 E7-pulsed dendritic cell vaccine by an adeno-shRNA-SOCS1 virus.
    Zhu Y, Zheng Y, Mei L, Liu M, Li S, Xiao H, Zhu H, Wu S, Chen H, Huang L.
    Int J Oncol; 2013 Oct; 43(4):1151-9. PubMed ID: 23877655
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Comparative study on anti-tumor immune response of autologous cytokine-induced killer (CIK) cells, dendritic cells-CIK (DC-CIK), and semi-allogeneic DC-CIK.
    Wang QJ, Wang H, Pan K, Li YQ, Huang LX, Chen SP, He J, Ke ML, Zhao JJ, Li JJ, Sun JC, Liang XT, Ma HQ, Chen YB, Xia JC.
    Chin J Cancer; 2010 Jul; 29(7):641-8. PubMed ID: 20591215
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effects of epidermal growth factor receptor fusion protein on the cytotoxic activity of SOCS1-silenced dendritic cells in vitro.
    Jiang Q, Wang X, Qian M, Chen D, Xu Y.
    Oncol Rep; 2018 Mar; 39(3):1306-1312. PubMed ID: 29286121
    [Abstract] [Full Text] [Related]

  • 9. Targeting the crosstalk between cytokine-induced killer cells and myeloid-derived suppressor cells in hepatocellular carcinoma.
    Yu SJ, Ma C, Heinrich B, Brown ZJ, Sandhu M, Zhang Q, Fu Q, Agdashian D, Rosato U, Korangy F, Greten TF.
    J Hepatol; 2019 Mar; 70(3):449-457. PubMed ID: 30414862
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Combining MPDL3280A with adoptive cell immunotherapy exerts better antitumor effects against cervical cancer.
    Zheng Y, Yang Y, Wu S, Zhu Y, Tang X, Liu X.
    Bioengineered; 2017 Jul 04; 8(4):367-373. PubMed ID: 27754760
    [Abstract] [Full Text] [Related]

  • 13. Cord blood-derived cytokine-induced killer cells combined with blinatumomab as a therapeutic strategy for CD19+ tumors.
    Golay J, Martinelli S, Alzani R, Cribioli S, Albanese C, Gotti E, Pasini B, Mazzanti B, Saccardi R, Rambaldi A, Introna M.
    Cytotherapy; 2018 Aug 04; 20(8):1077-1088. PubMed ID: 30093325
    [Abstract] [Full Text] [Related]

  • 14. Ex vivo allogeneic stimulation significantly improves expansion of cytokine-induced killer cells without increasing their alloreactivity across HLA barriers.
    Todorovic M, Mesiano G, Gammaitoni L, Leuci V, Giraudo Diego L, Cammarata C, Jordaney N, Carnevale-Schianca F, Gallo S, Fagioli F, Piacibello W, Elia AR, Pignochino Y, Dell'aglio C, Grignani G, Cignetti A, Aglietta M, Sangiolo D.
    J Immunother; 2012 Sep 04; 35(7):579-86. PubMed ID: 22892454
    [Abstract] [Full Text] [Related]

  • 15. [Tumor antigen-loaded dendritic cells combined with cytokine-induced killer (CIK) enhance the killing activity of human esophageal cancer cells by promoting ASK1 activation].
    Duan Z, Li H, Hu B, Li Y, Huang L.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Jun 04; 39(6):501-508. PubMed ID: 37340918
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. In vivo distribution and antitumor effect of infused immune cells in a gastric cancer model.
    Du X, Jin R, Ning N, Li L, Wang Q, Liang W, Liu J, Xu Y.
    Oncol Rep; 2012 Nov 04; 28(5):1743-9. PubMed ID: 22948809
    [Abstract] [Full Text] [Related]

  • 19. Biological activity of DC-CIK cells and its effect against leukemia cells in vitro.
    Wei XC, Zhai XH, Han XR, Yang DD, Zhao WL.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Oct 04; 16(5):1150-3. PubMed ID: 18928615
    [Abstract] [Full Text] [Related]

  • 20. Cytokine-induced killer cells co-cultured with complete tumor antigen-loaded dendritic cells, have enhanced selective cytotoxicity on carboplatin-resistant retinoblastoma cells.
    Wang YF, Kunda PE, Lin JW, Wang H, Chen XM, Liu QL, Liu T.
    Oncol Rep; 2013 May 04; 29(5):1841-50. PubMed ID: 23450314
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.